MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 ...

AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

Akeso Inc. scored U.S. FDA approval of the PD-1 monoclonal antibody penpulimab in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or ...

VYNE pauses VYN202 psoriasis trial after FDA clinical hold tied to animal toxicity data; separate vitiligo trial remains on ...

From famous celebrities to skincare gurus, social media videos about salmon sperm facials have been topping the charts on the ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

The hold, placed by the FDA on an early-stage clinical trial of an experimental BET inhibitor, stems from a recent ...

Vyne Therapeutics’ attempt to develop a safer, more tolerable BET inhibitor has hit turbulence. | Vyne Therapeutics’ attempt ...

VYNE has suspended all screening, enrollment and patient dosing in the Phase 1b trial of VYN202 and intends to work diligently with the FDA to resolve the clinical hold as soon as possible. To date, ...

First wearable device to monitor health by detecting gases emitted from and absorbed through the skin. Researchers at ...

Facial cupping is all over social media. Here, a dermatologist explains how it works, how it differs from body cupping, best ...